Did Elsevier break its own rules?

A science publisher that holds copyright supreme has a double standard, a science blogger is arguing. This week, science blogger Mike Dunford of linkurl:The Questionable Authority;http://scienceblogs.com/authority/ posted a linkurl:blog;http://scienceblogs.com/authority/2008/08/reed_elsevier_caught_copying_m.php saying that Reed Elsevier had copied some of the content from his blog without permission. While checking out links to his blog, Dunford came across a page run by LexisNexis (a Reed El

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A science publisher that holds copyright supreme has a double standard, a science blogger is arguing. This week, science blogger Mike Dunford of linkurl:The Questionable Authority;http://scienceblogs.com/authority/ posted a linkurl:blog;http://scienceblogs.com/authority/2008/08/reed_elsevier_caught_copying_m.php saying that Reed Elsevier had copied some of the content from his blog without permission. While checking out links to his blog, Dunford came across a page run by LexisNexis (a Reed Elsevier company), which contained excerpts from one of Dunford's posts on open access from a few weeks ago, which mentioned Elsevier's profits from 2007. Dunford's name didn't appear anywhere on the LexisNexis page, although there was a link back to the original blog post. Reed Elsevier has some open access content but primarily operates under the traditional publishing model. They have been vocal in their linkurl:opposition;http://www.the-scientist.com/blog/display/54442/ to open access. In his post this week, Dunford said: "I was not asked for, and did not give, permission for my work to appear on that page, much less in that format. Needless to say, I felt a little slighted." In a statement from LexisNexis sent to the The Scientist, the company said that the page is part of an internal database set up for Elsevier to keep track of what's being said about them in the media. So what's Dunford's beef? "I guess on a scale of one to 10 this does not even register too highly when talking about things like copyright," he told The Scientist. But the frustration, he added, is that "Elsevier expects people to properly attribute their products." Just this June, Elsevier, the publishing arm of the company, filed a copyright infringement suit against Encyclopedia Britannica over medical illustrations appearing in the encyclopedia. "If they want standards with how to treat intellectual property," Dunford added, "that type of thing begins at home." In the statement, LexisNexis agreed that proper attribution was not given on the page. "Whenever Web content generated by third parties is used in this way, it is the practice of LexisNexis to use only a small amount of that content, and to provide attribution to the content's author, along with a link to the relevant blog or Web site," the statement noted. "Our investigation concluded that, in this particular instance, these procedures were not adhered to fully." LexisNexis added that it will apologize to Dunford, remove the content in question, and implement refresher training for their employees to make sure content is attributed properly. "LexisNexis is committed to respecting the rights of copyright holders and content owners," the statement concluded.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo